Breaking News
Sort by:
Top Post
ProPharma Acquires UK Based Digital Lab Consulting
ProPharma Group (ProPharma) the leading global provider of regulatory, clinical, and quality services for the […]
Focus-X Therapeutics Successfully Reached an Acquisition Agreement with Full-Life Technologies
Focus-X Therapeutics, a nuclide drug company that was invested in and incubated by Viva Biotech, […]
Rocket Pharmaceuticals Completes Acquisition of Renovacor
Rocket Pharmaceuticals, a leading late-stage biotechnology company advancing an integrated and sustainable pipeline of genetic […]
AstraZeneca to Acquire Neogene Therapeutics, Accelerating Ambition in Oncology Cell Therapy
AstraZeneca has announced an agreement to acquire Neogene Therapeutics, a global clinical-stage biotechnology company pioneering […]
Audax Private Equity Announces Acquisition of Medi-Weightloss, Inc.
Audax Private Equity announced the acquisition of Medi-Weightloss, a leading operator of science-based, physician-supervised weight-loss […]
Clarify Pharma Acquires Shares in Atai Life Sciences and Compass Pathways
Clarify Pharma, an investment vehicle specialising in biotech and life sciences companies seeking to prove […]
BioIVT Acquires Fidelis Research
BioIVT, a leading provider of biospecimens, research models and services for drug and diagnostic development, today […]
Concord Health Partners Adds Healthcare Private Equity Veteran Robert Schulz as Managing Director
Concord Health Partners (“Concord” or the “Firm”), a healthcare focused investment firm, today announced that […]
Gilead Sciences Completes Acquisition of MiroBio
GMiroBioilead Sciences, Inc. (Nasdaq: GILD) today announced the completion of the previously announced transaction to […]
GENFIT Acquires Swiss Biotech Versantis for Over CHF105 Million
GENFIT (Nasdaq and Euronext: GNFT), a late-stage biopharmaceutical company dedicated to improving the lives of […]
BioIVT Acquires XenoTech, a Leading Provider of Products and Services for Preclinical Testing of New Drug Candidates
BioIVT, a leading provider of biospecimens, research models and services for drug and diagnostic development, today […]
- Insmed Completes Enrollment of Adult Patients in Phase 3 ASPEN Study of Brensocatib in Bronchiectasis Read more
- NEC Establishes Subsidiaries in Europe for Strengthening Global AI Drug Development Business Read more
- Flare Therapeutics Further Strengthens Leadership Team with Key Executive Appointments and Promotions Read more
- Sensorion Appoints Khalil Barrage as Interim Chairman of the Board Read more
- Ablaze Pharmaceuticals Plans Development of Innovative GPC3 Targeted Radiopharmaceutical Therapy for Liver Cancer in Greater China Read more